BIOGEN INC. Debt Instrument, Redemption Price, Percentage
BIOGEN INC. (BIIB) reported Debt Instrument, Redemption Price, Percentage of 100.00% for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-03.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentRedemptionPricePercentage · last filed 2021-02-03
- BIOGEN INC. debt instrument, redemption price, percentage for fiscal 2020 was 100.00%, a 0.00% change from fiscal 2019.
- BIOGEN INC. debt instrument, redemption price, percentage for fiscal 2019 was 100.00%, a 0.00% change from fiscal 2018.
- BIOGEN INC. debt instrument, redemption price, percentage for fiscal 2018 was 100.00%, a 0.00% change from fiscal 2017.
- BIOGEN INC. debt instrument, redemption price, percentage for fiscal 2017 was 100.00%, a 0.00% change from fiscal 2016.
| Period end | Debt Instrument, Redemption Price, Percentage 9 month | Debt Instrument, Redemption Price, Percentage 12 month |
|---|---|---|
| 2020-12-31 | 100.00% 10-K · filed 2021-02-03 | |
| 2019-12-31 | 100.00% 10-K · filed 2020-02-06 | |
| 2018-12-31 | 100.00% 10-K · filed 2019-02-06 | |
| 2017-12-31 | 100.00% 10-K · filed 2018-02-01 | |
| 2016-12-31 | 100.00% 10-K · filed 2017-02-02 | |
| 2015-12-31 | 100.00% 10-K · filed 2016-02-03 | |
| 2015-09-30 | 100.00% 10-Q · filed 2015-10-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |